1Gershon AS, Warner L, Cascagnette P, et al. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study [ J ]. Lancet, 2011, 378 (9795) : 991-996.
2Demoly P, Annunziata K, Gubba E, et al. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years[J]. Eur Respir Rev, 2012, 21(23) : 66-74.
3Peters SP, Jones CA, Affiliations Division of Allergy and Immunology,Department of Pediatrics, Los Angeles County and University of Southem California Medical Center, Los AngelesHaselkom T, et al. Real-world Evaluation of Asthma Control and Treatment (REACT) : Findings from a national Web-based survey [ J ]. J Allergy ClinImmunol, 2007, 119(6) : 1454-1461.
4Boulet LP, FitzGerald JM, Levy ML, etal. A guide to the translation of the Global Initiative for Asthma ( GINA ) strategy into improved care[J]. Eur Respir J, 2012, 39(5) : 1220-1229.
5Haahtela T, Tuomisto LE, Pietinalho A, etal. A 10 year asthma programme in Finland : major change for the better [ J ]. Thorax, 2006, 61(8) : 663-670.
6Green RH, Brighfling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial [ J ]. Lancet, 2002, 360(9347): 1715-1721.
7Powell H, Murphy VE, Taylor DR, et al. Management of asthma in preguancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial[ J ]. Lancet, 2011,378 (9795) : 983-990.
